Adam Koppel Insider Trading $SLDB Solid Biosciences Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adam Koppel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Adam Koppel in Solid Biosciences Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adam Koppel: Director
Holdings: 7,060,353 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Adam Koppel in Solid Biosciences Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 3.70 | 3,189,189 | 11,799,999 | 7,060,353 | 3.9 M to 7.1 M (+82.38 %) |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 10,000 | 30,300 | 10,000 | |
| Jun 18 2020 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
| Jul 30 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Grant | A | 4.65 | 1,881,720 | 8,749,998 | 3,871,164 | 2 M to 3.9 M (+94.59 %) |
| Jun 17 2019 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 5.26 | 10,000 | 52,600 | 10,000 | |
| Dec 17 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 23.58 | 8,165 | 192,531 | 8,165 | |
| Jul 27 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 37.89 | 1,835 | 69,528 | 1,835 | |
| Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | M | 0.00 | 1,991,097 | 0 | 0 | |
| Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Option Exercise | A | 0.00 | 1,223,240 | 0 | 1,991,097 | |
| Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Buy | P | 16.00 | 300,000 | 4,800,000 | 1,989,444 | 1.7 M to 2 M (+17.76 %) |
| Feb 01 2018 | SLDB | Solid Biosciences ... | Koppel Adam | Director | Buy | M | 0.00 | 1,689,444 | 0 | 1,689,444 | 0 to 1.7 M |
Page: 1